Medifast, Inc.

MEDNYSEConsumer Cyclical● Active

$12.10

$-0.17(-1.39%)

Market Cap$134541110

P/E Ratio—

52W High$15.46

52W Low$9.22

Avg Volume236K

Open$12.35

Beta0.66

Overview

Medifast, Inc. (MED) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

MED · free cash flow · updated Jun 8, 2026

Core FCF metrics

MED · FCF · TTM · margin & CAGR

Free cash flow was $1.2M for FY2025 (fiscal year ending 2025-12-31), down 92.7% year-over-year The FCF margin was 0.3%. Five-year CAGR stands at -61.0%.

FY2025 Free Cash Flow$1.2M▼ -92.7% YoY

Trailing 12M (TTM)−$1.5MTrailing 4Q sum · TTM negative vs latest FY positive

FCF Margin0.3%$1.2M ÷ revenue

3-Year CAGR-80.8%FY2022 → FY2025

5-Year CAGR-61.0%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

MED · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$6.9M(6M)$1.2M▼ 92.7%0.3%

FY2024$24.5M(7M)$17.0M▼ 87.9%2.8%

FY2023$147.7M(6M)$141.2M▼ 20.6%13.2%

FY2022$194.6M(17M)$177.9M▲ +194.8%11.1%

FY2021$94.5M(34M)$60.3M▼ 56.7%4.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

MED · P/FCF · FCF yield · FCF per share

Medifast, Inc. (MED) valuation ratios are currently unavailable — market cap, share count, or TTM data could not be retrieved from our data provider.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

Valuation ratios are unavailable — market cap, share count, or TTM data could not be retrieved. Individual metrics are shown where available.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

MED · cash flow statement · operating / investing / financing

For FY2025, Medifast, Inc. generated $6.9M in operating cash flow and spent 6M in capital expenditures, yielding $1.2M in free cash flow.

Operating Activities

+$6.9M

Cash from core business operations

2025-12-31

Investing Activities

−$7.9M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$0.6M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($6.9M) − |CapEx| (6M) = FCF ($1.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Consumer Cyclical)

MED vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Medifast, Inc.YOU

MED

$1.2M-92.7%0.3%

Toyota Motor Corporation

Alibaba Group Holding Limited

BABA

−$50.72B-164.9%-5.0%

Loss

Consumer Cyclical · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Medifast, Inc. (MED) reported free cash flow of $1.2M for FY2025 (fiscal year ending 2025-12-31), down 92.7% year-over-year. The FCF margin was 0.3%.

Based on available data, Medifast, Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $177.9M in FY2022. The 5-year CAGR stands at -61.0%.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

MED free cash flow · 8 questions

Medifast, Inc. free cash flow was $1.2M for FY2025, down 92.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$1.5M.

MED free cash flowMED FCFMED FCF 2025MED free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Medifast, Inc. · Medifast, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026